February 2022
Volume 22, Issue 3
Open Access
Optica Fall Vision Meeting Abstract  |   February 2022
Invited Session I: Artificial intelligence applications in ophthalmology and vision science: AI applications in glaucoma
Author Affiliations
  • Hiroshi Ishikawa
    Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University
Journal of Vision February 2022, Vol.22, 41. doi:https://doi.org/10.1167/jov.22.3.41
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hiroshi Ishikawa; Invited Session I: Artificial intelligence applications in ophthalmology and vision science: AI applications in glaucoma. Journal of Vision 2022;22(3):41. doi: https://doi.org/10.1167/jov.22.3.41.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Glaucoma is the second cause of blindness worldwide. Due to the complicated non-linear relationships between structural and functional assessment outcomes together with the large variabilities of disease progression patterns, accurate and reliable clinical assessment is a paramount importance for this slow but irreversible progressing disease. Recent advances in medical applications of artificial intelligence, especially deep learning (DL) approaches, have opened up unprecedented possibilities in computer aided clinical care. I will discuss a variety of DL studies on our large longitudinal glaucoma cohort data in collaborating IBM Watson Research Team. The topics include: 1) estimation of visual field parameters out of raw 3D optical coherence tomography (OCT) image data using a feature agnostic data driven approach, 2) forecasting functional measurements out of clinically available demographic information augmented by OCT feature analysis, 3) generating future 2D biomarker color mapping on OCT image data, and 4) identifying novel biomarkers and exploration of structure-function relationships using a group class activation mapping technique.

Footnotes
 Funding: NIH R01-EY013178, NIH R01-EY030929, P30EY013079 (unrestricted grant by the Research to Prevent Blindness).
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×